Ambisome and Graft versus host disease - a phase IV clinical study of FDA data
We study 7,710 people who have side effects when taking Ambisome. Graft versus host disease is found, especially among people who are male, 40-49 old, have been taking the drug for < 1 month, also take Neupogen and have Fungal infection.
The phase IV clinical study analyzes which people take Ambisome and have Graft versus host disease. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
7,710 people reported to have side effects when taking Ambisome.
Among them, 108 people (1.4%) have Graft versus host disease.
What is Ambisome?
Ambisome has active ingredients of amphotericin b. Currently, eHealthMe is studying from 7,716 Ambisome users.
What is Graft versus host disease?
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body) is found to be associated with 1,088 drugs and 618 conditions by eHealthMe. Currently, we are studying 16,525 people who have Graft versus host disease.
Number of Ambisome and Graft versus host disease reports submitted per year:
Time on Ambisome when people have Graft versus host disease *:
Gender of people who have Graft versus host disease when taking Ambisome*:
Age of people who have Graft versus host disease when taking Ambisome *:
Common drugs people take besides Ambisome *:
Common side effects people have besides Graft versus host disease *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ambisome and have Graft versus host disease?Check whether Graft versus host disease is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Ambisome side effects by duration, gender and age:
- Ambisome side effects (7,716 reports)
Graft versus host disease treatments and more:
- Graft versus host disease (16,525 reports)
Common drugs associated with Graft versus host disease:
- Cyclosporine: 1,859 reports
- Fludara: 1,613 reports
- Methotrexate: 1,593 reports
- Cyclophosphamide: 1,477 reports
- Tacrolimus: 1,305 reports
- Mycophenolate mofetil: 1,077 reports
- Prednisone: 897 reports
- Busulfan: 874 reports
- Prograf: 857 reports
- Prednisolone: 751 reports
All the drugs that are associated with Graft versus host disease:
- Graft versus host disease (1,088 drugs)
Common conditions associated with Graft versus host disease:
- Acute lymphocytic leukemia (all): 394 reports
- Preventive health care: 325 reports
- Immunodeficiency disorders: 296 reports
- Multiple myeloma: 280 reports
All the conditions that are associated with Graft versus host disease:
- Graft versus host disease (618 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on amphotericin b (the active ingredients of Ambisome) and Ambisome (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ativan and Serevent drug interaction - now
- Otezla and Sprintec drug interaction - 2 seconds ago
- Methyltestosterone and Fever - 9 seconds ago
- Vitamins and Cephalexin drug interaction - 10 seconds ago
- Tradjenta and Tpn drug interaction - 17 seconds ago
- Ibuprofen and Pressure Ulcer - 20 seconds ago
- Albuterol and Dimetane drug interaction - 24 seconds ago
- Zomig and Albuterol drug interaction - 26 seconds ago
- Ciclopirox and Chlorpheniramine Maleate drug interaction - 30 seconds ago
- Tramadol Hydrochloride And Acetaminophen and Escitalopram drug interaction - 32 seconds ago